MIB Seminar (in English)
(Joint Usage/Research Center for the Multi-stratified Host Defense System)
FY 2018
- "Targeting Cell Signaling Pathways for Cancer Therapies", Prof. Wenyi Wei (2019-03-05)
- "GLP and drug safety studies- Hints for academic researchers", Abbas Fotovati, DVM, PhD (2019-02-18)
- "Ferroptosis in Cancer Research", Prof. Shinya Toyokuni (2019-01-29)
- "First-in-class drug development strategy for Parkinson’s disease via interruption of death signaling", Dr. Eunhee Kim (2018-11-21)
- "Epigenetics in the male germline from stem cells to sperm", Dr. Satoshi Namekawa (2018-11-15)
- "Democratizing Health Innovation", Dr. Martin Burke (2018.11.13)
- "The Role of OGG1 in doxorubicin-induced cardiotoxicity", Dr. Chukwuemeka George Anene-Nzelu (2018-11-01)
- "Epigenetic pathways as targets in human disease", Prof. Shelley L. Berger (2018-09-05)
- "Regulations of mitotic processes by nucleosomes — molecular principles and implications in cancer biology and immunology", Hironori Funabiki, Ph.D. (2018-06-20)